Information  X 
Enter a valid email address

InnovaDerma PLC (IDP)

  Print      Mail a friend

Friday 16 April, 2021

InnovaDerma PLC

Director/PDMR Shareholding

RNS Number : 7472V
InnovaDerma PLC
16 April 2021
 

InnovaDerma PLC

("InnovaDerma" or the "Company")

 Director/PDMR shareholding

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, announces it was notified yesterday that, Mark Ward, Non-executive Director has purchased 171,242 Ordinary shares of €0.10 each in the Company at an average price of 40.7 pence per Ordinary Share.

Following the purchase, Mark Ward now holds a total of 2,345,919 Ordinary Shares representing approximately 13.49% of the issued share capital of the Company. In addition, Mark Ward has agreed to subscribe for 1,428,571 new ordinary shares pursuant to the conditional placing as announced on 20 January 2021.

In addition, InnovaDerma was notified yesterday that, Andrew Dunderdale, Group Finance Director has purchased 24,937 Ordinary shares of €0.10 each in the Company at a price of 40.1 pence per Ordinary Share. Following the Purchase, Andrew Dunderdale now holds Ordinary Shares representing approximately 0.14% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries  

InnovaDerma  

Blake Hughes 

c/o TB Cardew 

finnCap Ltd  

Geoff Nash/Kate Bannatyne 

Alice Lane - Corporate Broking 

+44 (0)207 220 0500 

www.finncap.com 

TB Cardew  

Shan Shan Willenbrock/ 

Olivia Rosser 

+ 44 (0)7775 848537 

+ 44 (0)20 7930 0777 

[email protected]  

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Ward

2. 

Reason for the Notification

 

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP   GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume - 2,345,919 Ordinary Shares

Average Price - 40.7 pence per Ordinary Share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

15 April 2021

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Dunderdale

2. 

Reason for the Notification

 

a)

Position/status

Group Finance Director

b)

Initial notification/Amendment

Initial notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP   GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume - 24,937 o rdinary Shares

Average Price - 40.1 pence per Ordinary Share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

15 April 2021

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUNVKRAWUSARR

a d v e r t i s e m e n t